A selective and potent non-peptide angiotensin II type 2 (AT2) receptor antagonist. Potential treatment of cardiac hypertrophy as blockage of AT2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Studies show that it has protective effect against tumor necrosis factor-alpha-induced damage to human renal proximal tubular epithelial cells Form: Pale Beige Solid Melting Point: 111-114C Solubility: Chloroform, Methanol Pfizer Compound
Molekulargewicht:
736.66
Formulierung:
Pale Beige Solid
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
